Abstract
Urine-blood (U-B)Pco2 difference in children is usually assessed following urine alkalinization with oral sodium bicarbonate (NaHCO3). Since oral NaHCO3 is often poorly tolerated by children, we compared oral acetazolamide with oral NaHCO3 in a study of (U-B)Pco2. In the first phase of the study 14 children and adolescents aged 11.1±3.7 years (mean±SD) were studied. Eight participants had normal kidney function and 6 had disturbed distal acidification capacity. Each child was studied twice, once with oral NaHCO3 (2.5 mEq/kg) and once with acetazolamide (17±2 mg/kg). All studies were performed according to the standard protocol. Acetazolamide administration resulted in a lower blood pH than NaHCO3 (7.30±0.03 vs 7.38±0.06,P<0.001) and a lower serum bicarbonate (HCO3 −) concentration (25.1±2.2 mEq/l vs 27.5±2.1 mEq/l,P<0.025). Acetazolamide also resulted in a higher urinePco2 (81.9±26.2 mm Hg vs 71.6±18.2 mm Hg) than NaHCO3 (P<0.025). No significant differences between acetazolamide and NaHCO3 were observed with respect to their effects on urinary pH and HCO3 − concentration, plasmaPco2 and (U-B)Pco2. Good linear correlations were found between the effects of acetazolamide and NaHCO3 on urinePco2 (r=0.878,P<0.001), and on (U-B)Pco2 (r=0.795,P<0.01). Using either method of urinary alkalization, children with normal kidney function had urinePco2 greater than or equal to 80 mm Hg and (U-B)Pco2 greater than or equal to 30 mm Hg, and those with disturbed acidification capacity had urinePco2 less than or equal to 70 mm Hg and (U-B)Pco2 less than or equal to 20 mm Hg. Patient satisfaction with the test, on a scale of 1 (worst) to 5 (best), was 2.6±0.8 for NaHCO3 and 3.9±0.3 for acetazolamide (P<0.001). Tests with NaHCO3 lasted 150.9±30.5 min versus 115.7±18.1 min for acetazolamide (P<0.01). In the second phase of the study 8 children, 5 with normal and 3 with abnormal acidification capacity were studied twice with oral acetazolamide. Studies were performed 3 weeks apart. The results showed very good reproducibility of (U-B)Pco2 in all of the subjects. Oral acetazolamide and NaHCO3 have similar effects on (U-B)Pco2 but the diuretic agent shortens the testing time and is easier to administer to children. We conclude that oral acetazolamide could be substituted for NaHCO3 under certain circumstances in the assessment of (U-B)Pco2.
Similar content being viewed by others
References
Kurtzman NA (1983) Acquired distal renal tubular acidosis. Kidney Int 24: 807–819
Batlle DC, Grupp M, Gaviria M, Kurtzman NA (1982) Distal renal tubular acidosis with intact ability to lower urine pH. Am J Med 72: 751–758
Halperin ML, Goldstein MB, Haig A, Johnson MD, Stinebaugh BJ (1974) Studies on the pathogenesis of type I (distal) renal tubular acidosis as revealed by the urinary Pco2 tensions. J Clin Invest 53: 669–677
Arruda JAL, Nascimento L, Kumar SK, Kurtzman NA (1977) Factors influencing the formation of urinary carbon dioxide tension. Kidney Int 11: 307–317
DuBose TD Jr, Pucaccco LR, Green JM (1982) Hydrogen ion secretion by the collecting duct as a determinant of the urine to blood Pco2 gradient in alkaline urine. J Clin Invest 69: 145–156
Donckerwolcke RA, Valk C, Van Wijngaarden-Penterman MJG, Van Stekelenburg JG (1983) The diagnostic value of the urine to blood carbon dioxide tension gradient for the assessment of distal tubular hydrogen secretion in pediatric patients with renal tubular disorders. Clin Nephrol 19: 254–258
Hutcheon RA, Kaplan BS, Drummond KN (1976) Distal renal tubular acidosis in children with chronic hydronephrosis. J Pediatr 89: 372–376
Halperin ML, Goldstein MB, Richardson RMA, Stinebaugh BJ (1985) Distal renal tubular acidosis syndromes: a pathophysiological approach. Am J Nephrol 5: 1–8
Bentur L, Alon U, Mandel H, Pery M, Berant M (1989) Familial distal renal tubular acidosis with neurosensory deafness: early nephrocalcinosis. Am J Nephrol 9: 470–474
Tulassay T, Miltenyi M, Dobos M (1986) Alterations of urinary carbon dioxide tension, electrolyte handling and low molecular weight protein excretion in acute pyelonephritis. Acta Paediatr Scand 75: 415–419
Thirakomen K, Kozlov N, Arruda JAL, Kurtzman NA (1976) Renal hydrogen ion secretion after release of unilateral ureteral obstruction. Am J Physiol 231: 1233–1239
Tessitore N, Ortalda V, Fabris A, D'Angelo A, Rugiu C, Oldrizzi L, Lupo A, Valvo E, Gammaro L, Loschiava C, Panzetta G, Panebianco R, Bedogna V, Maschio G (1985) Renal acidification defects in patients with recurrent calcium nephrolithiasis. Nephron 41: 325–332
Perez GO, Oster JR, Sonneborn RE, Magrinat G, Vaamonde CA (1977) Urinary carbon dioxide tension in lithium carbonate-treated patients. J Pharmacol Exp Ther 201: 456–462
Batlle DC, Gaviria M, Grupp M, Arruda JAL, Kurtzman NA (1982) Distal nephron function in patients receiving chronic lithium therapy. Kidney Int 21: 477–485
Georgaki-Angelaki HN, Steed DB, Chantler C, Haycock GB (1989) Renal function following acute renal failure in childhood: a long term follow-up study. Kidney Int 35: 84–89
Rubinstein H, Batlle DC, Roseman M, Sehy JT, Arruda JAL, Kurtzman NA (1981) Urinary Pco2 during carbonic anhydrase inhibition in the dog. Miner Electrolyte Metab 5: 49–59
Goldstein MB, Levin A (1989) Insights derived from the urine in acid-base disturbances. AKF Nephrol Lett 6: 19–26
Hastings AB, Sendroy J Jr (1925) The effects of variations in ionic strength on the apparent first and second dissociation constants of carbonic acid. J Biol Chem 65: 445–455
Kurtzman NA (1970) Regulation of renal bicarbonate reabsorption by extracellular volume. J Clin Invest 49: 586–595
Bourke E, Delaney VB, Mosawi M, Reavey P, Weston M (1981) Renal tubular acidosis and osteopetrosis in siblings. Nephron 28: 268–272
Sly WS, Hewett-Emmett D, Whyte MP, Yu YSL, Tashian RE (1983) Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc Natl Acad Sci USA 80: 2752–2756
Sly WS, Whyte MP, Sundaram V, Tashian RE, Hewett-Emmett D, Guibaud P, Vainsel M, Balauarte HJ, Gruskin A, Al-Mosawi M, Sakati N, Ohlsson A (1985) Carbonic anhydrase II deficiency in 12 families with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. N Engl J Med 313: 139–145
Wistrand PJ (1984) Properties of membrane-bound carbonic anhydrase. Ann N Y Acad Sci 429: 195–206
Wistrand PJ, Knuuttila KG (1989) Renal membrane-bound carbonic anhydrase. Purification and properties. Kidney Int 35: 851–859
Gougoux A, Vinay P, Lemieux G, Richardson RMA, Tam SC, Goldstein MG, Stinebaugh BJ, Halperin ML (1980) Effect of blood pH on distal nephron hydrogen ion secretion. Kidney Int 17: 615–621
Bichara M, Mercier O, Houillier P, Paillard M, Leviel F, Marty E (1987) Effects of antidiuretic hormone on urinary acidification and on tubular handling of bicarbonate in the rat. J Clin Invest 80: 621–630
Nutbourne DM, de Wardener HE (1960) The effect of a water diuresis on the urinary excretion of hydrogen ions in man. Clin Sci 20: 63–73
Tam SC, Goldstein MB, Richardson RMA, Robson WLM, Stinebaugh BJ, Halperin ML (1980) Effect of extracellular fluid volume contraction on distal-nephron hydrogen ion secretion in vivo. J Lab Clin Med 96: 442–459
Varade WS, Clardy CJ, Pan C, McEnery PT, Leahy AE, Strife CF (1989) The urine minus blood Pco2 gradient (U-BpCo2) distinguishes rate dependent distal renal tubular acidosis (dRTA) from classical dRTA in children. Pediatr Res 25: 350A
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Alon, U., Hellerstein, S. & Warady, B.A. Oral acetazolamide in the assessment of (urine-blood)PCO2 . Pediatr Nephrol 5, 307–311 (1991). https://doi.org/10.1007/BF00867488
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00867488